# Proton Beam Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery

> **NCT01076231** · PHASE1,PHASE2 · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 34 (actual)

## Conditions studied

- Stage IIIA Non-small Cell Lung Cancer

## Interventions

- **RADIATION:** proton beam radiation therapy
- **DRUG:** cisplatin
- **DRUG:** etoposide
- **PROCEDURE:** therapeutic conventional surgery

## Key facts

- **NCT ID:** NCT01076231
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2016-12
- **Final completion:** 2018-05-24
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2021-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01076231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01076231, "Proton Beam Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01076231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*